parthenolide has been researched along with Osteolysis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bishop, RT; Idris, AI; Logan, JG; Marino, S; Mollat, P | 1 |
| Li, Y; Mao, Y; Wang, H; Wang, X; Zhang, C; Zhou, X | 1 |
| Cantley, MD; Crotti, TN; Dharmapatni, AA; Haynes, DR; Marino, V; Perilli, E; Purdue, PE; Xu, J; Zawawi, MS | 1 |
| Feng, HT; Joyce, DA; Steer, JH; Xu, J; Yip, KH; Zheng, MH | 1 |
4 other study(ies) available for parthenolide and Osteolysis
| Article | Year |
|---|---|
Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis.
Topics: Animals; Apoptosis; beta Catenin; Bone Neoplasms; Breast Neoplasms; Cell Differentiation; Cell Proliferation; Dose-Response Relationship, Drug; Female; Humans; MCF-7 Cells; Mice, Inbred BALB C; Mice, Inbred C57BL; NF-kappa B; Osteoblasts; Osteoclasts; Osteogenesis; Osteolysis; Sesquiterpenes; Signal Transduction; Time Factors | 2017 |
Parthenolide inhibits polyethylene particle-induced mouse calvarial osteolysis in vivo.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Lactones; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Osteolysis; Polyethylene; Prosthesis Failure; Sesquiterpenes; Skull; X-Ray Microtomography | 2014 |
Parthenolide reduces empty lacunae and osteoclastic bone surface resorption induced by polyethylene particles in a murine calvarial model of peri-implant osteolysis.
Topics: Animals; Bone Resorption; Collagen Type I; Humans; Mice; Models, Animal; Organ Size; Osteoarthritis; Osteoclasts; Osteolysis; Peptides; Polyethylene; Prostheses and Implants; Receptors, Cell Surface; Sesquiterpenes; Skull; Solubility; X-Ray Microtomography | 2015 |
Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
Topics: Active Transport, Cell Nucleus; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Blotting, Western; Bone and Bones; Bone Resorption; Cell Differentiation; Dose-Response Relationship, Drug; Flow Cytometry; Gene Expression Regulation; Genes, Reporter; Glycoproteins; Green Fluorescent Proteins; Interleukin-1; Lactones; Lipopolysaccharides; Luciferases; Macrophages; Mice; Mice, Inbred C57BL; Microscopy, Confocal; NF-kappa B; Osteoclasts; Osteolysis; Osteoprotegerin; Protein Transport; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Time Factors; TNF Receptor-Associated Factor 6; Transcription, Genetic; Tumor Necrosis Factor-alpha | 2004 |